FDA is being very careful and rightly so. From the little we know, the bad news are that patients might develop serious allergic reaction to the treatment, and the good part is it wasn't fatal and resolved after one day hospitalization. We'll need to hear more details like if it was single treatment and of course to know what does the FDA say.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.